1. UNAIDS. AIDS Epidemic Update - Special report on HIV/AIDS - December 2006. Geneva: UNAIDS; 2006.
2. UNICEF. Children affected by AIDS. New York: UNICEF; 2006. Africa’s Orphaned and Vulnerable Generations.
3. De Cock KM, Fowler MG, Mercier E, de Vincenzi I, Saba J, Hoff E, et al. Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA. 2000;283:1175–1182. [PubMed]
4. WHO. Recommendations for a public health approach. Geneva: WHO; 2006. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants in resource-limited settings. Towards universal access; p. 92.
5. Stanton CK, Holtz SA. Levels and trends in cesarean birth in the developing world. Stud Fam Plann. 2006;37:41–48. [PubMed] 6. Wiktor SZ, Ekpini E, Karon JM, Nkengasong J, Maurice C, Severin ST, et al. Short- course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d’Ivoire: a randomised trial. Lancet. 1999;353:781–785. [PubMed] 7. Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 1999;354:795–802. [PubMed] 8. Shaffer N, Chuachoowong R, Mock PA, Bhadrakom C, Siriwasin W, Young NL, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet. 1999;353:773–780. [PubMed] 9. Dabis F, Msellati P, Meda N, Welffens-Ekra C, You B, Manigart O, et al. 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Cote d’Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study Group. DIminution de la Transmission Mere-Enfant. Lancet. 1999;353:786–792. [PubMed] 10. Dabis F, Bequet L, Ekouevi DK, Viho I, Rouet F, Horo A, et al. Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission. Aids. 2005;19:309–318. [PMC free article] [PubMed] 11. Lallemant M, Jourdain G, Le Coeur S, Mary JY, Ngo-Giang-Huong N, Koetsawang S, et al. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med. 2004;351:217–228. [PubMed] 12. Petra study team. Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial. Lancet. 2002;359:1178–1186. [PubMed] 13. Leroy V, Sakarovitch C, Cortina-Borja M, McIntyre J, Coovadia H, Dabis F, et al. Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa? Aids. 2005;19:1865–1875. [PubMed] 14. Jackson JB, Musoke P, Fleming T, Guay LA, Bagenda D, Allen M, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. Lancet. 2003;362:859–868. [PubMed] 15. Eshleman SH, Jackson JB. Nevirapine resistance after single dose prophylaxis. AIDS Rev. 2002;4:59–63. [PubMed] 16. Arrive E, Newell ML, Ekouevi DK, Chaix ML, Thiebaut R, Masquelier B, et al. Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis. Int J Epidemiol. 2007 doi: 10.1093/ije/dym104. [PubMed] [Cross Ref] 17. McIntyre J. Preventing mother-to-child transmission of HIV: successes and challenges. BJOG. 2005;112:1196–1203. [PubMed] 18. Chaix ML, Ekouevi DK, Rouet F, Tonwe-Gold B, Viho I, Bequet L, et al. Low risk of nevirapine resistance mutations in the prevention of mother-to-child transmission of HIV-1: Agence Nationale de Recherches sur le SIDA Ditrame Plus, Abidjan, Cote d’Ivoire. J Infect Dis. 2006;193:482–487. [PubMed] 19. Tonwe-Gold B, Ekouevi DK, Viho I, Amani-Bosse C, Toure S, Coffie PA, et al. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach. PLoS Med. 2007;4:e257. [PMC free article] [PubMed]
20. Palombi L, Germano P, Liotta G, Guidootti G, Narcisco P, Perno CF, et al. DREAM Program: 6-month follow-up of the prevention of mother-to-child transmission service. 13th Conference on Retroviruses and Opportunistic Infections; 5–8 February 2006; Denver (USA). 2006.
21. Cotter AM, Garcia AG, Duthely ML, Luke B, O’Sullivan MJ. Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth? J Infect Dis. 2006;193:1195–1201. [PubMed] 22. Thorne C, Patel D, Newell ML. Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe. AIDS. 2004;18:2337–2339. [PubMed] 23. Briand N, Lallemant M, Jourdain G, Techapalokul S, Tunthanathip P, Suphanich S, et al. Haematological Safety of Perinatal Zidovudine in Pregnant HIV-1-Infected Women in Thailand: Secondary Analysis of a Randomized Trial. PLoS Clin Trials. 2007;2:e11. [PMC free article] [PubMed] 24. Leroy V, Karon JM, Alioum A, Ekpini ER, Meda N, Greenberg AE, et al. Twenty- four month efficacy of a maternal short-course zidovudine regimen to prevent mother-to-child transmission of HIV-1 in West Africa. AIDS. 2002;16:631–641. [PubMed] 25. WHO Collaborative Study Team on the Role of Breastfeeding on the Prevention of Infant Mortality. Effect of breastfeeding on infant and child mortality due to infectious diseases in less developed countries: a pooled analysis. Lancet. 2000;355:451–455. [PubMed] 26. Breastfeeding and HIV International Transmission Study Group. Late postnatal transmission of HIV-1 in breast-fed children: An individual patient data meta- analysis. J Infect Dis. 2004;189:2154–2166. [PubMed] 27. Leroy V, Karon JM, Alioum A, Ekpini ER, Van de Perre P, Greenberg AE, et al. Postnatal transmission of HIV-1 after a maternal short-course zidovudine peripartum regimen in West Africa. AIDS. 2003;17:1493–1501. [PubMed] 28. Taha TE, Hoover DR, Kumwenda NI, Fiscus SA, Kafulafula G, Nkhoma C, et al. Late postnatal transmission of HIV-1 and associated factors. J Infect Dis. 2007;196:10–14. [PubMed] 29. Coutsoudis A, Pillay K, Kuhn L, Spooner E, Tsai WY, Coovadia HM. Method of feeding and transmission of HIV-1 from mothers to children by 15 months of age: prospective cohort study from Durban, South Africa. AIDS. 2001;15:379–387. [PubMed] 30. Iliff PJ, Piwoz EG, Tavengwa NV, Zunguza CD, Marinda ET, Nathoo KJ, et al. Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival. AIDS. 2005;19:699–708. [PubMed] 31. Coovadia HM, Rollins NC, Bland RM, Little K, Coutsoudis A, Bennish ML, Newell ML. Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study. Lancet. 2007;369:1107–1116. [PubMed] 32. Becquet R, Ekouevi DK, Viho I, Sakarovitch C, Toure H, Castetbon K, et al. Acceptability of exclusive breastfeeding with early cessation to prevent HIV transmission through breastmilk, ANRS 1201/1202 Ditrame Plus, Abidjan, Côte d’Ivoire. J Acquir Immune Defic Syndr. 2005;40:600–608. [PMC free article] [PubMed] 33. Leroy V, Sakarovitch C, Viho I, Becquet R, Ekouevi DK, Bequet L, et al. Acceptability of formula-feeding to prevent HIV postnatal transmission, Abidjan, Cote d’Ivoire - ANRS 1201/1202 Ditrame Plus study. Jaids Journal of Acquired Immune Deficiency Syndromes. 2007;44:77–86. [PubMed] 34. Becquet R, Ekouevi DK, Sakarovitch C, Viho I, Bequet L, Fassinou P, et al. Two- year morbidity and mortality and alternatives to prolonged breastfeeding among children born to HIV-infected mothers: ANRS 1201/1202 Ditrame Plus, Abidjan, Côte d’Ivoire. PLoS Med. 2007;4:e17. [PMC free article] [PubMed] 35. Thior I, Lockman S, Smeaton LM, Shapiro RL, Wester C, Heymann SJ, et al. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana - A randomized trial: The Mashi study. JAMA. 2006;296:794–805. [PubMed] 36. Bahl R, Frost C, Kirkwood BR, Edmond K, Martines J, Bhandari N, Arthur P. Infant feeding patterns and risks of death and hospitalization in the first half of infancy: multicentre cohort study. Bull World Health Organ. 2005;83:418–426. [PubMed] 37. Doherty T, Chopra M, Nkonki L, Jackson D, Greiner T. Effect of the HIV epidemic on infant feeding in South Africa: “When they see me coming with the tins they laugh at me” Bull World Health Organ. 2006;84:90–96. [PubMed]
38. Kourtis AP, Fitzgerald D, Hyde L, Tien HC, Chavula C, Mumba N, et al. Diarrhea in uninfected infants of HIV-infected mothers who stop breastfeeding at 6 months: the BAN study experience. 14th Conference on Retroviruses and Opportunistic Infections; Los Angeles (USA). February 25–28 2007.
39. Thomas T, Masaba R, van Eijk A, Ndivo R, Nasokho P, Thigpen M, Fowler MG. Rates of diarrhea associated with early weaning among infants in Kisumu, Kenya. 14th Conference on Retroviruses and Opportunistic Infections; Los Angeles (USA). February 25–28 2007.
40. Sinkala M, Kuhn L, Kankasa C, Kasonde P, Vwalika C, Mwiya M, et al. No benefit of early cessation of breastfeeding at 4 months on HIV-free survival of infants born to HIV-infected mothers in Zambia: the Zambia Exclusive Breastfeeding Study. 14th Conference on Retroviruses and Opportunistic Infections; Los Angeles (USA). February 25–28 2007.
41. Bland RM, Rollins NC, Coovadia HM, Coutsoudis A, Newell ML. Infant feeding counselling for HIV-infected and uninfected women: appropriateness of choice and practice. Bull World Health Organ. 2007;85:289–296. [PubMed]
42. World Health Organisation. WHO HIV and Infant Feeding Technical Consultation Held on behalf of the Inter-agency Task Team (IATT) on Prevention of HIV Infections in Pregnant Women, Mothers and their Infants; Geneva. October 25–27, 2006; Geneva: World Health Organisation; 2006.
43. Jeffery BS, Mercer KG. Pretoria pasteurisation: a potential method for the reduction of postnatal mother to child transmission of the human immunodeficiency virus. J Trop Pediatr. 2000;46:219–223. [PubMed] 44. Israel-Ballard K, Chantry C, Dewey K, Lonnerdal B, Sheppard H, Donovan R, et al. Viral, nutritional, and bacterial safety of flash-heated and Pretoria-pasteurized breast milk to prevent mother-to-child transmission of HIV in resource-poor countries: a pilot study. J Acquir Immune Defic Syndr. 2005;40:175–181. [PubMed] 45. Gaillard P, Fowler MG, Dabis F, Coovadia H, vanderHorst C, vanRompay K, et al. Use of antiretroviral drugs to prevent HIV-1 transmission through breast-feeding: From animal studies to randomized clinical trials. J Acquir Immune Defic Syndr. 2004;35:178–187. [PubMed]
46. Becquet R. Antiretroviral therapy among HIV-infected breastfeeding mothers: a promising strategy to prevent HIV transmission through breastmilk in Africa. Future HIV Therapy. 2007;1:17–21.
47. Leroy V, Ekouevi DK, Dequae-Merchadou L, Viho I, Becquet R, Tonwe-Gold B, et al. 18-month effectiveness of short-course perinatal antiretroviral regimens combined to infant-feeding interventions for PMTCT in Abidjan, Côte d’Ivoire. DITRAME PLUS ANRS 1201/1202 2001–2005. XVI International AIDS Conference; 13–18 August 2006; Toronto (Canada). 2006.
48. UNAIDS. 2006 Report on the global AIDS epidemic. Geneva: UNAIDS; 2006.
49. Thaineua V, Kanshana S, Thewanda D, Amornwichet P, Kullerk N, Voramongkol N, et al. Evaluation of a regional pilot program to prevent mother-infant HIV transmission - Thailand, 1998–2000 (Reprinted from MMWR, vol 50, pg 599, 2001) JAMA. 2001;286:784–786. [PubMed] 50. Perez-Then E, Pena R, Tavarez-Rojas M, Pena C, Quinonez S, Buttler M, et al. Preventing mother-to-child HIV transmission in a developing country: the Dominican Republic experience. J Acquir Immune Defic Syndr. 2003;34:506–511. [PubMed] 51. Stringer EM, Sinkala M, Stringer JS, Mzyece E, Makuka I, Goldenberg RL, et al. Prevention of mother-to-child transmission of HIV in Africa: successes and challenges in scaling-up a nevirapine-based program in Lusaka, Zambia. AIDS. 2003;17:1377–1382. [PMC free article] [PubMed] 52. Behets F, Matendo R, Vaz LME, Kilese N, Nanlele D, Kokolomami J, et al. Preventing vertical transmission of HIV in Kinshasa, Democratic Republic of the Congo: a baseline survey of 18 antenatal clinics. Bulletin of the World Health Organization. 2006;84:969–975. [PubMed] 53. Jackson DJ, Chopra M, Doherty TM, Colvin MSE, Levin JB, Willumsen JF, et al. Operational effectiveness and 36 week HIV-free survival in the South African programme to prevent mother-to-child transmission of HIV-1. Aids. 2007;21:509–516. [PubMed] 54. Perez F, Zvandaziva C, Engelsmann B, Dabis F. Acceptability of routine HIV testing (“opt-out”) in antenatal services in two rural districts of Zimbabwe. J Acquir Immune Defic Syndr. 2006;41:514–520. [PubMed]
55. Chandisarewa W, Stranix-Chibanda L, Chirapa E, Miller A, Simoyi M, Mahomva A, et al. Routine offer of antenatal HIV testing (“opt-out” approach) to prevent mother-to-child transmission of HIV in urban Zimbabwe. Bull World Health Organ. In press.
56. World Health Organisation, UNAIDS. Guidance on provider-initiated HIV testing and counselling in health facilities. Geneva: World Health Organisation; May, 2007. p. 56.
57. Painter TM. Voluntary counseling and testing for couples: a high-leverage intervention for HIV/AIDS prevention in sub-Saharan Africa. Soc Sci Med. 2001;53:1397–1411. [PubMed] 58. Homsy J, Kalamya JN, Obonyo J, Ojwang J, Mugumya R, Opio C, Mermin J. Routine intrapartum HIV counseling and testing for prevention of mother-to- child transmission of HIV in a rural Ugandan hospital. J Acquir Immune Defic Syndr. 2006;42:149–154. [PubMed] 59. Newell ML, Coovadia H, Cortina Borja M, Rollins N, Gaillard P, Dabis F. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet. 2004;364:1236–1243. [PubMed] 60. Prendergast A, Tudor-Williams G, Jeena P, Burchett S, Goulder P. International perspectives, progress, and future challenges of paediatric HIV infection. Lancet. 2007;370:68–80. [PubMed] 61. Rouet F, Ekouevi DK, Chaix ML, Burgard M, Inwoley A, Tony TD, et al. Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting. J Clin Microbiol. 2005;43:2709–2717. [PMC free article] [PubMed] 62. Ou CY, Yang H, Balinandi S, Sawadogo S, Shanmugam V, Tih PM, et al. Identification of HIV-1 infected infants and young children using real-time RT PCR and dried blood spots from Uganda and Cameroon. J Virol Methods. 2007;144:109–114. [PubMed]
63. WHO. Recommendations for a public health approach. Geneva: World Health Organisation; 2006. Antiretroviral therapy of HIV infection in infants and children: towards universal access.
64. Sherman GG, Stevens G, Jones SA, Horsfield P, Stevens WS. Dried blood spots improve access to HIV diagnosis and care for infants in low-resource settings. J Acquir Immune Defic Syndr. 2005;38:615–617. [PubMed] 65. Lucas SB, Peacock CS, Hounnou A, Brattegaard K, Koffi K, Honde M, et al. Disease in children infected with HIV in Abidjan, Cote d’Ivoire. Bmj. 1996;312:335–338. [PMC free article] [PubMed] 66. Zar HJ, Cotton MF, Strauss S, Karpakis J, Hussey G, Schaaf HS, et al. Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial. Bmj. 2007;334:136. [PMC free article] [PubMed] 67. Chintu C, Bhat GJ, Walker AS, Mulenga V, Sinyinza F, Lishimpi K, et al. Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial. Lancet. 2004;364:1865–1871. [PubMed]
68. WHO. Recommendations for a public health approach. Geneva: WHO; 2006. Guidelines on co-trimoxazole prophylaxis for HIV-related infections among children, adolescents and adults in resource-limited settings; p. 64.
69. Fassinou P, Elenga N, Rouet F, Laguide R, Kouakoussui KA, Timite M, et al. Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Cote d’Ivoire. AIDS. 2004;18:1905–1913. [PubMed] 70. Gortmaker SL, Hughes M, Cervia J, Brady M, Johnson GM, Seage GR, 3rd, et al. Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. N Engl J Med. 2001;345:1522–1528. [PubMed] 71. Puthanakit T, Oberdorfer A, Akarathum N, Kanjanavanit S, Wannarit P, Sirisanthana T, Sirisanthana V. Efficacy of highly active antiretroviral therapy in HIV-infected children participating in Thailand’s National Access to Antiretroviral Program. Clin Infect Dis. 2005;41:100–107. [PubMed] 72. Rouet F, Fassinou P, Inwoley A, Anaky MF, Kouakoussui A, Rouzioux C, et al. Long-term survival and immuno-virological response of African HIV-1-infected children to highly active antiretroviral therapy regimens. Aids. 2006;20:2315–2319. [PubMed] 73. Thorne C, Gray L, Newell ML. Management of vertically HIV-infected children in Europe. Acta Paediatr. 2003;92:246–250. [PubMed] 74. Newell ML, Patel D, Goetghebuer T, Thorne C. CD4 cell response to antiretroviral therapy in children with vertically acquired HIV infection: is it associated with age at initiation? J Infect Dis. 2006;193:954–962. [PubMed] 75. Faye A, Le Chenadec J, Dollfus C, Thuret I, Douard D, Firtion G, et al. Early versus deferred antiretroviral multidrug therapy in infants infected with HIV type 1. Clin Infect Dis. 2004;39:1692–1698. [PubMed]
76. Violari A, Cotton M, Gibb D, Babiker A, Steyn J, Jean-Philippe P, McIntyre J. ART initiated before 12 weeks reduces early mortality in young children HIV-infected infants: evidence from the children with HIV Early Antiretroviral Therapy (CHER) Study. 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention; Sydney (Australia). 22–25 July 2007.
77. Barlow-Mosha L, Musoke P, Ajuna P, Luttajumwa M, Walabyeki J, Owor M, Mubiru M. Early effectiveness of Triomune in HIV infected Ugandan children. 3rd IAS Conference on HIV Pathogenesis and Treatment; 24–27 July 2005; Rio de Janeiro (Brazil). 2005.
78. Chokephaibulkit K, Plipat N, Cressey TR, Frederix K, Phongsamart W, Capparelli E, et al. Pharmacokinetics of nevirapine in HIV-infected children receiving an adult fixed-dose combination of stavudine, lamivudine and nevirapine. AIDS. 2005;19:1495–1499. [PubMed] 79. O’Brien DP, Sauvageot D, Zachariah R, Humblet P. In resource-limited settings good early outcomes can be achieved in children using adult fixed-dose combination antiretroviral therapy. Aids. 2006;20:1955–1960. [PubMed] 80. Menson EN, Walker AS, Sharland M, Wells C, Tudor-Williams G, Riordan FA, et al. Underdosing of antiretrovirals in UK and Irish children with HIV as an example of problems in prescribing medicines to children, 1997–2005: cohort study. BMJ. 2006;332:1183–1187. [PMC free article] [PubMed] 81. Calmy A, Klement E, Teck R, Berman D, Pecoul B, Ferradini L. Simplifying and adapting antiretroviral treatment in resource-poor settings: a necessary step to scaling-up. AIDS. 2004;18:2353–2360. [PubMed] 82. Lockman S, Shapiro RL, Smeaton LM, Wester C, Thior I, Stevens L, et al. Response to antiretroviral therapy after a single, peripartum dose of nevirapine. N Engl J Med. 2007;356:135–147. [PubMed] 83. Myer L, Moodley K, Hendricks F, Cotton M. Healthcare providers’ perspectives on discussing HIV status with infected children. J Trop Pediatr. 2006;52:293–295. [PubMed] 84. Moodley K, Myer L, Michaels D, Cotton M. Paediatric HIV disclosure in South Africa - caregivers’ perspectives on discussing HIV with infected children. S Afr Med J. 2006;96:201–204. [PubMed] 85. Mellins CA, Brackis-Cott E, Dolezal C, Abrams EJ. The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2004;23:1035–1041. [PubMed] 86. Wiener L, Mellins CA, Marhefka S, Battles HB. Disclosure of an HIV diagnosis to children: history, current research, and future directions. J Dev Behav Pediatr. 2007;28:155–166. [PMC free article] [PubMed] 87. Bikaako-Kajura W, Luyirika E, Purcell DW, Downing J, Kaharuza F, Mermin J, et al. Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda. AIDS Behav. 2006;10:S85–93. [PubMed] 88. De Baets AJ, Bulterys M, Abrams EJ, Kankassa C, Pazvakavambwa IE. Care and treatment of HIV-infected children in Africa: issues and challenges at the district hospital level. Pediatr Infect Dis J. 2007;26:163–173. [PubMed] 89. Kline MW. Perspectives on the pediatric HIV/AIDS pandemic: catalyzing access of children to care and treatment. Pediatrics. 2006;117:1388–1393. [PubMed]
90. Doherty T, Beeser M, Donohue S, Kamoga N, Stoops N, Williamson L, Visser R. An evaluation of the prevention of mother-to-child transmission (PMTCT) of HIV initiative in South Africa, lessons and key recommendations. Durban (South Africa): Health Systems Trust; 2003.
91. Stranix-Chibanda L, Chandisarerwa W, Chirapa E, Shetty A. Low return rates for routine follow-up of HIV-exposed infants at primary care level in an urban area of Zimbabwe. PEPFAR Implementers Meeting; 12–15 June 2006; Durban (South Africa).
92. Kober K, Van Damme W. Scaling up access to antiretroviral treatment in southern Africa: who will do the job? Lancet. 2004;364:103–107. [PubMed] 93. Schneider H, Blaauw D, Gilson L, Chabikuli N, Goudge J. Health systems and access to antiretroviral drugs for HIV in Southern Africa: service delivery and human resources challenges. Reprod Health Matters. 2006;14:12–23. [PubMed] 94. Rollins N, Little K, Mzolo S, Horwood C, Newell ML. Surveillance of mother-to-child transmission prevention programmes at immunization clinics: the case for universal screening. Aids. 2007;21:1341–1347. [PubMed] 95. Horwood C, Liebeschuetz S, Blaauw D, Cassol S, Qazi S. Diagnosis of paediatric HIV infection in a primary health care setting with a clinical algorithm. Bull World Health Organ. 2003;81:858–866. [PubMed] 96. Jones SA, Sherman GG, Coovadia AH. Can clinical algorithms deliver an accurate diagnosis of HIV infection in infancy? Bull World Health Organ. 2005;83:559–560. [PubMed] 97. Braitstein P, Brinkhof MW, Dabis F, Schechter M, Boulle A, Miotti P, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006;367:817–824. [PubMed] 98. Dabis F, Balestre E, Braitstein P, Miotti P, Brinkhof WG, Schneider M, et al. Cohort profile: Antiretroviral Therapy in Lower Income Countries (ART-LINC): international collaboration of treatment cohorts. Int J Epidemiol. 2005;34:979–986. [PubMed] 99. Ferradini L, Jeannin A, Pinoges L, Izopet J, Odhiambo D, Mankhambo L, et al. Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet. 2006;367:1335–1342. [PubMed]
100. Arrivé E, Marquis B, Tumwesiye N, Cotton M, Holland M, Renner L, et al. Response to ART in Children in Sub-Saharan Africa: A Pooled Analysis of Clinical Databases, the KIDS-ART-LINC Collaboration. 14th Conference on Retroviruses and Opportunistic Infections; Los Angeles (USA). February 25–28 2007.
101. MboriNgacha D, Kyabayinze D, Arrivé E, Marquis B, Tumwesigye N, Kieffer MP, et al. Paediatric ART in Sub-Saharan Africa: program characteristics in the multi-center international KIDS-ART-LINC collaboration. XVI International AIDS Conference; Toronto (Canada). 13–18 August 2006.
102. George E, Noel F, Bois G, Cassagnol R, Estavien L, Rouzier Pde M, et al. Antiretroviral therapy for HIV-1-infected children in Haiti. J Infect Dis. 2007;195:1411–1418. [PubMed]
103. WHO. An update on “3 by 5”. Geneva: World Health Organisation; Jun, 2005. Progress on Global Access to HIV Antiretroviral Therapy.
104. Office of the United States Global AIDS Coordinator. First Annual Report to Congress. Washington (USA): Office of the United States Global AIDS Coordinator; 2006. Engendering bold leadership: The president’s emergency plan for AIDS relief.
105. Mailman School of Public Health - Columbia University. MTCT-Plus Initiative Activity Report. Annual report year 3. New York (USA): Mailman School of Public Health - Columbia University; Jan–Dec. 2004.
106. Elizabeth Glaser Pediatric AIDS Foundation. International Family AIDS Initiatives. 2006.
107. Reddi A, Leeper SC, Grobler AC, Geddes R, France KH, Dorse GL, et al. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa. BMC Pediatr. 2007;7:7–13. [PMC free article] [PubMed] 108. Arrive E, Kyabayinze DJ, Marquis B, Tumwesigye N, Kieffer MP, Azondekon A, et al. Cohort Profile: The Paediatric Antiretroviral Treatment Programmes in Lower-Income Countries (KIDS-ART-LINC) Collaboration. Int J Epidemiol. 2007 [PubMed] 109. Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, Chintu N, Stringer EM, Chi BH, et al. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. Jama. 2007;298:1888–1899. [PubMed] 110. Ngweshemi J, Urassa T, Isingo T, Mwaluko G, Ngalula J, Boerma T, et al. HIV impact on mother and child mortality in rural Tanzania. J Acquir Immune Defic Syndr. 2003;33:393–404. [PubMed] 111. Nakiyingi JS, Bracher M, Whitworth JA, Ruberantwari A, Busingye J, Mbulaiteye SM, Zaba B. Child survival in relation to mother’s HIV infection and survival: evidence from a Ugandan cohort study. AIDS. 2003;17:1827–1834. [PubMed] 112. Watts H, Gregson S, Saito S, Lopman B, Beasley M, Monasch R. Poorer health and nutritional outcomes in orphans and vulnerable young children not explained by greater exposure to extreme poverty in Zimbabwe. Trop Med Int Health. 2007;12:584–593. [PubMed] 113. Miller CM, Gruskin S, Subramanian SV, Heymann J. Emerging health disparities in Botswana: examining the situation of orphans during the AIDS epidemic. Soc Sci Med. 2007;64:2476–2486. [PubMed]
114. USAID/Zambia. Results of the Orphans and Vulnerable Children Head of Household Baseline Survey in Four Districts in Zambia. Displaced Children and Orphans Fund; SCOPE-OVC/Zambia, Family Health International; 2002.
115. Sengendo J, Nambi J. The psychological effect of orphanhood: a study of orphans in Rakai district. Health Transit Rev. 1997;7 (Suppl):105–124. [PubMed] 116. Atwine B, Cantor-Graae E, Bajunirwe F. Psychological distress among AIDS orphans in rural Uganda. Soc Sci Med. 2005;61:555–564. [PubMed] 117. Pillay AL, Lockhat MR. Developing community mental health services for children in South Africa. Soc Sci Med. 1997;45:1493–1501. [PubMed]
118. UNAIDS. A case study in Zimbabwe and the United Republic of Tanzania. Geneva: UNAIDS; 2001. Investing in our future, psychosocial support for children affected by HIV/AIDS; p. 75.
119. Case A, Paxson C, Ableidinger J. Orphans in Africa: parental death, poverty, and school enrollment. Demography. 2004;41:483–508. [PubMed]
120. Nyamukapa C, Foster G, Gregson S. Orphans’ household circumstances and access to education in a maturing HIV epidemic in eastern Zimbabwe. J Soc Dev Afr. 2003;18:7–32.
121. Madhavan S. Fosterage patterns in the age of AIDS: continuity and change. Soc Sci Med. 2004;58:1443–1454. [PubMed]
122. UNICEF. Africa’s orphaned generations. New-York: UNICEF; 2003.
123. Ntozi JP. Effect of AIDS on children: the problem of orphans in Uganda. Health Transit Rev. 1997;7 (Suppl):23–40. [PubMed] 124. Foster G, Williamson J. A review of current literature on the impact of HIV/AIDS on children in sub-Saharan Africa. AIDS. 2000;14:S275–284. [PubMed]
125. Audemard C, Kokou V, Desgrees du Loû A. Les Numériques du CEPED. Paris: CEPED; 2006. Orphelins et enfants vulnérables à cause du Sida en Afrique. (sous la direction)
126. Monasch R, Boerma JT. Orphanhood and childcare patterns in sub-Saharan Africa: an analysis of national surveys from 40 countries. AIDS. 2004;18 (Suppl 2):S55–65. [PubMed] 127. Foster G. Supporting community efforts to assist orphans in Africa. N Engl J Med. 2002;346:1907–1910. [PubMed] 128. Miller CM, Gruskin S, Subramanian SV, Rajaraman D, Heymann SJ. Orphan care in Botswana’s working households: growing responsibilities in the absence of adequate support. Am J Public Health. 2006;96:1429–1435. [PubMed] 129. Jackson H, Kerkhoven R. Developing AIDS care in Zimbabwe: a case for residential community centres? AIDS Care. 1995;7:663–673. [PubMed] 130. Matshalaga NR, Powell G. Mass orphanhood in the era of HIV/AIDS. BMJ. 2002;324:185–186. [PMC free article] [PubMed]
131. Family Health International. A strategic framework. Arlington (USA): Family Health International; 2001. Care for orphans, children affected by HIV/AIDS and other vulnerable children.
132. UNAIDS, UNICEF, USAID. Children on the Brink 2004. A joint report of new orphan estimates and a framework for action. Geneva (Switzerland), New-York (USA), Washington (USA): UNAIDS, UNICEF, USAID; 2004.